Adia Nutrition (ADIA) Total Current Liabilities (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Total Current Liabilities came in at $1.1 million in Q1 2026, up 48.91% quarter-over-quarter from $745195.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Total Current Liabilities (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Total Current Liabilities for 3 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Total Current Liabilities changed N/A year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $745195.0, up 831.58% from the prior year.
- Total Current Liabilities was $1.1 million for Q1 2026 at Adia Nutrition, up from $745195.0 in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.1 million in Q1 2026 and troughed at $79993.0 in Q4 2024.
- A 3-year average of $644953.3 and a median of $745195.0 in 2025 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 831.58% in 2025, down 831.58% in 2025.
- Over 3 years, Total Current Liabilities stood at $79993.0 in 2024, then jumped by 831.58% to $745195.0 in 2025, then surged by 48.91% to $1.1 million in 2026.
- The last three Total Current Liabilities figures came in at $1.1 million (Q1 2026), $745195.0 (Q4 2025), and $79993.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 127.40 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 132.90 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 106.85 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 403.60 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 83.35 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 29.35 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 80.88 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 502.91 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 52.53 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 745,195.00 |
| Dec 31, 2024 | 79,993.00 |